MicroLight Gene

MicroLight Gene

微光基因

MicroLight Gene

Biotech/Healthcare

Founded in Suzhou in 2021, Weiguang Gene is focused on the R&D and commercialization of novel gene-editing technologies, using new gene-editing tools and cell and gene therapy methods as its foundation. Its team has extensive expertise in gene editing, protein science, aging, rare diseases, and…

Latest round: Pre Series A (2026)

Source: ChinaBulls — chinabulls.com

Last updated 2026-09-09

Funding history

Request access to view this section.

Investors

Request access to view this section.

HQ & website

Request access to view this section.

Tags

Request access to view this section.